• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来源于霍乱弧菌 O1 类脂体的耳蜗酯:结构转化对黏膜免疫的影响。

Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.

机构信息

Research and Development Vice-presidency of Finlay Institute, Havana, Cuba.

出版信息

PLoS One. 2012;7(10):e46461. doi: 10.1371/journal.pone.0046461. Epub 2012 Oct 12.

DOI:10.1371/journal.pone.0046461
PMID:23077508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3470579/
Abstract

Cochleates are phospholipid-calcium precipitates derived from the interaction of anionic lipid vesicles with divalent cations. Proteoliposomes from bacteria may also be used as a source of negatively charged components, to induce calcium-cochleate formation. In this study, proteoliposomes from V. cholerae O1 (PLc) (sized 160.7±1.6 nm) were transformed into larger (16.3±4.6 µm) cochleate-like structures (named Adjuvant Finlay Cochleate 2, AFCo2) and evaluated by electron microscopy (EM). Measurements from transmission EM (TEM) showed the structures had a similar size to that previously reported using light microscopy, while observations from scanning electron microscopy (SEM) indicated that the structures were multilayered and of cochleate-like formation. The edges of the AFCo2 structures appeared to have spaces that allowed penetration of negative stain or Ovalbumin labeled with Texas Red (OVA-TR) observed by epi-fluorescence microscopy. In addition, freeze fracture electron microscopy confirmed that the AFCo2 structures consisted of multiple overlapping layers, which corresponds to previous descriptions of cochleates. TEM also showed that small vesicles co-existed with the larger cochleate structures, and in vitro treatment with a calcium chelator caused the AFCo2 to unfold and reassemble into small proteoliposome-like structures. Using OVA as a model antigen, we demonstrated the potential loading capacity of a heterologous antigen and in vivo studies showed that with simple admixing and administration via intragastric and intranasal routes AFCo2 provided enhanced adjuvant properties compared with PLc.

摘要

脂钙体是阴离子脂质体与二价阳离子相互作用产生的磷脂钙沉淀物。细菌的类脂蛋白体也可用作带负电荷成分的来源,以诱导钙脂钙体的形成。在这项研究中,霍乱弧菌 O1 的类脂蛋白体(PLc)(大小为 160.7±1.6nm)被转化为更大的(16.3±4.6µm)类似脂钙体的结构(命名为辅助芬莱脂钙体 2,AFCo2),并通过电子显微镜(EM)进行评估。透射电子显微镜(TEM)的测量结果显示,这些结构的大小与之前使用光学显微镜报道的相似,而扫描电子显微镜(SEM)的观察结果表明,这些结构是多层的,呈脂钙体样形成。AFCo2 结构的边缘似乎有空隙,允许负染或用 Texas Red 标记的卵清蛋白(OVA-TR)渗透,通过荧光显微镜观察到。此外,冷冻断裂电子显微镜证实,AFCo2 结构由多个重叠的层组成,这与之前对脂钙体的描述相符。TEM 还显示,小囊泡与较大的脂钙体结构共存,并且体外用钙螯合剂处理会导致 AFCo2 展开并重新组装成小的类脂蛋白体样结构。使用 OVA 作为模型抗原,我们证明了异源抗原的潜在载药能力,体内研究表明,与 PLc 相比,通过简单混合并通过灌胃和鼻腔途径给药,AFCo2 提供了增强的佐剂特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/92239db4fe48/pone.0046461.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/e331c71fde54/pone.0046461.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/d59469e4454f/pone.0046461.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/55e6b3c6fc24/pone.0046461.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/970f58116ad6/pone.0046461.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/1a7c6d434171/pone.0046461.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/92239db4fe48/pone.0046461.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/e331c71fde54/pone.0046461.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/d59469e4454f/pone.0046461.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/55e6b3c6fc24/pone.0046461.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/970f58116ad6/pone.0046461.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/1a7c6d434171/pone.0046461.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45c/3470579/92239db4fe48/pone.0046461.g006.jpg

相似文献

1
Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.来源于霍乱弧菌 O1 类脂体的耳蜗酯:结构转化对黏膜免疫的影响。
PLoS One. 2012;7(10):e46461. doi: 10.1371/journal.pone.0046461. Epub 2012 Oct 12.
2
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.经鼻给予霍乱弧菌 O1 来源的脂膜泡衍生的耳蜗体可诱导小鼠黏膜和全身免疫应答。
Methods. 2009 Dec;49(4):309-15. doi: 10.1016/j.ymeth.2009.03.027. Epub 2009 Jun 21.
3
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.利用脑膜炎奈瑟菌 B 群的类脂体和空斑结构进行黏膜免疫接种可诱导黏膜和全身应答。
Methods. 2009 Dec;49(4):301-8. doi: 10.1016/j.ymeth.2009.03.025. Epub 2009 May 4.
4
Understanding cochleate formation: insights into structural development.理解螺旋形结构的形成:对结构发育的见解
Soft Matter. 2016 Apr 20;12(16):3797-809. doi: 10.1039/c5sm01469g.
5
Fluorescence properties of Laurdan in cochleate phases.月桂酰基罗丹明(Laurdan)在螺旋状相中的荧光特性。
Biochim Biophys Acta. 2003 Dec 3;1618(1):67-78. doi: 10.1016/j.bbamem.2003.10.009.
6
Nanocochleates containing N-Octylglicoside extracted Vibrio cholerae antigens elicited high vibriocidal antibodies titers after intragastric immunization in a mice model.纳米胶束包含从霍乱弧菌中提取的 N-辛基葡萄糖苷抗原,在小鼠模型中经胃内免疫后可诱导产生高滴度的杀菌抗体。
Microb Pathog. 2021 Jul;156:104902. doi: 10.1016/j.micpath.2021.104902. Epub 2021 Apr 27.
7
Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern.基于含有天然脂多糖作为病原体相关分子模式的蛋白脂质体衍生螺旋体结构的新型佐剂。
Immunol Cell Biol. 2004 Dec;82(6):603-10. doi: 10.1111/j.1440-1711.2004.01293.x.
8
Feasibility of the preparation of cochleate suspensions from naturally derived phosphatidylserines.从天然来源的磷脂酰丝氨酸制备螺旋状脂质体悬浮液的可行性。
Front Med Technol. 2023 Sep 6;5:1241368. doi: 10.3389/fmedt.2023.1241368. eCollection 2023.
9
Strategy for determination of an efficient Cochleate particle size.
Vaccine. 2006 Apr 12;24 Suppl 2:S2-92-3. doi: 10.1016/j.vaccine.2005.01.138.
10
Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.基于减毒霍乱弧菌的抗原呈递平台的舌下佐剂传递。
mSphere. 2018 Jun 6;3(3). doi: 10.1128/mSphere.00245-18. Print 2018 Jun 27.

引用本文的文献

1
Encapsulation of Cochleates Derived from Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine.用生物聚合物包裹源自婴儿双歧杆菌的卷曲螺旋结构以开发一种潜在的口服家禽疫苗。
Polymers (Basel). 2021 Oct 6;13(19):3426. doi: 10.3390/polym13193426.

本文引用的文献

1
Remodelling of the Vibrio cholerae membrane by incorporation of exogenous fatty acids from host and aquatic environments.霍乱弧菌膜的重塑是通过整合来自宿主和水生环境的外源性脂肪酸来实现的。
Mol Microbiol. 2011 Feb;79(3):716-28. doi: 10.1111/j.1365-2958.2010.07476.x. Epub 2010 Dec 7.
2
Mucosal vaccines: recent progress in understanding the natural barriers.黏膜疫苗:对天然屏障的理解的最新进展。
Pharm Res. 2010 Feb;27(2):211-23. doi: 10.1007/s11095-009-0011-3. Epub 2009 Dec 1.
3
Mucosal vaccines: novel advances in technology and delivery.
黏膜疫苗:技术与递送方面的新进展
Expert Rev Vaccines. 2009 Aug;8(8):1083-97. doi: 10.1586/erv.09.61.
4
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.经鼻给予霍乱弧菌 O1 来源的脂膜泡衍生的耳蜗体可诱导小鼠黏膜和全身免疫应答。
Methods. 2009 Dec;49(4):309-15. doi: 10.1016/j.ymeth.2009.03.027. Epub 2009 Jun 21.
5
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?递送系统:一种克服黏膜耐受性的疫苗策略?
Expert Rev Vaccines. 2009 Jan;8(1):103-12. doi: 10.1586/14760584.8.1.103.
6
New vaccines require potent adjuvants like AFPL1 and AFCo1.新疫苗需要像AFPL1和AFCo1这样有效的佐剂。
Scand J Immunol. 2007 Aug-Sep;66(2-3):271-7. doi: 10.1111/j.1365-3083.2007.01981.x.
7
Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs.猪体内双相脂质囊泡制剂中细菌抗原和CpG寡核苷酸的黏膜递送
AAPS J. 2005 Oct 14;7(3):E566-71. doi: 10.1208/aapsj070357.
8
Uptake and presentation of orally administered antigens.口服抗原的摄取与呈递。
Vaccine. 2005 Mar 7;23(15):1793-6. doi: 10.1016/j.vaccine.2004.11.007.
9
Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles.囊泡大小会影响脂质囊泡中抗原的运输、加工和呈递。
J Immunol. 2004 Nov 15;173(10):6143-50. doi: 10.4049/jimmunol.173.10.6143.
10
Absorption enhancers for nasal drug delivery.用于鼻腔给药的吸收促进剂。
Clin Pharmacokinet. 2003;42(13):1107-28. doi: 10.2165/00003088-200342130-00003.